Paused
Vascularized Composite Bladder Allograft Transplantation
NCT05462561 · University of Southern California · Updated 18 June 2026
- What is being tested
- Quality-of-Life Assessment; Robotic Vascularized Composite Bladder Allograft Transplantation
- For
- Neurogenic Bladder; Bladder Dysfunction; Immunosuppression
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 5 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 May 2023, ends 3 Oct 2028. Registered 18 July 2022.
- Results
- None posted yet.
In the researchers' words
This phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tolerated alternative to standard urinary diversion, which employs bowel. A robotic surgical approach will be employed.
Sites
- USC / Norris Comprehensive Cancer CenterLos Angeles, California, United States